Search
forResearch 10 of 72
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- A summary of in vitro, phase I, and phase II studies evaluating the mechanism of action, safety, and efficacy of clascoterone (cortexolone 17a propionate, CB-03-01) in androgenetic alopecia
- Cortexolone 17a-propionate: A new antiandrogen acting on hair dermal papilla cells for the treatment of androgenic alopecia
- Cortexolone 17a-propionate: Preclinical profile of a new topical, skin selective, steroidal antiandrogen
- Emerging Therapies for Acne Vulgaris
- Topical Antiandrogen Therapies for Androgenetic Alopecia and Acne Vulgaris
- Differential diagnosis of trichotillomania by trichoscopy
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Clascoterone as a novel treatment for androgenetic alopecia
- A review of diagnosis and treatment of acne in adult female patients
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →